Evaxion AS (EVAX)
4.12
-0.02
(-0.48%)
USD |
NASDAQ |
Apr 15, 16:00
4.12
0.00 (0.00%)
After-Hours: 18:29
Evaxion Research and Development Expense (Annual) : 9.691M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Novo Nordisk A/S | 6.838B |
| Ascendis Pharma A/S | 333.10M |
| DBV Technologies SA | 107.12M |
| Cellectis SA | 75.08M |
| Akari Therapeutics Plc | 2.822M |